entity

claudin_5

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about claudin_5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
7Hypotheses
3Analyses
1Outgoing
1Incoming
0Experiments
4Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
tight_junctionsmaintainspathway0.80

Incoming (1)

SourceRelationTypeStr
CLDN5encodesgene0.80

Targeting Hypotheses (7)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Epigenetic 0.712 - Blood-brain barrier permeability changes
Plasma Claudin-5 Proteolytic Fragments Distinguish Paracellu 0.680 - What blood-brain barrier permeability ch
S100B as Active Pathogenic BBB-Disrupting Signal via RAGE/NF 0.647 - Blood-brain barrier permeability changes
Endothelial miR-181c-5p Upregulation Drives Claudin-5 Repres 0.620 - What blood-brain barrier permeability ch
Circulating Endothelial Microvesicles Expressing Degraded Cl 0.615 - What blood-brain barrier permeability ch
Matrix Metalloproteinase-9-Mediated Claudin-5 Cleavage Drive 0.490 - What blood-brain barrier permeability ch
HBOT at 1.5 ATA for 90 days restores BBB integrity by upregu 0.460 neurodegeneration What are the optimal oxygen pressure, du

Mentioning Analyses (3)

Scientific analyses that reference this entity

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

neurodegeneration | 2026-04-26 | 5 hypotheses Top: 0.712

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.919

Blood-brain barrier transport mechanisms for antibody therapeutics

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.773

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (4)

Multi-agent debates referencing this entity

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

active · Rounds: 7 · Score: 0.00 · 2026-04-26

Should PEA-PPARA endocannabinoid signaling be prioritized as a therapeutic strat

closed · Rounds: 4 · Score: 0.76 · 2026-04-23

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

closed · Rounds: 7 · Score: 0.87 · 2026-04-16

Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% brain penetrance. Engi

closed · Rounds: 4 · Score: 0.91 · 2026-04-06

Related Research

Hypotheses and analyses mentioning claudin_5 in their description or question text

Matrix Metalloproteinase-9-Mediated Claudin-5 Cleavage Drives Early Tight Juncti

Score: 0.490 · unknown disease · 2026-04-26

Neuroinflammation triggers astrocyte and microglial MMP-9 activation, which proteolytically cleaves claudin-5, the princ

HBOT at 1.5 ATA for 90 days restores BBB integrity by upregulating claudin-5 and

Score: 0.460 · neurodegeneration · 2026-04-25

HBOT promotes pericyte survival via PDGF-BB/PDGFR-β signaling and upregulates claudin-5 transcription through HIF-2α to